| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.42▼ | 3.40▲ | 3.41▲ | 3.45▼ | 2.88▲ |
| MA10 | 3.40▲ | 3.43▼ | 3.38▲ | 3.38▲ | 2.81▲ |
| MA20 | 3.39▲ | 3.37▲ | 3.39▲ | 2.93▲ | 2.88▲ |
| MA50 | 3.43▼ | 3.44▼ | 3.51▼ | 2.78▲ | 3.64▼ |
| MA100 | 3.38▲ | 3.51▼ | 3.16▲ | 2.88▲ | 3.11▲ |
| MA200 | 3.39▲ | 3.10▲ | 2.83▲ | 3.67▼ | 2.62▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.009▲ | 0.007▲ | 0.011▲ | 0.056▲ | 0.108▲ |
| RSI | 54.367▲ | 52.348▲ | 50.206▲ | 63.623▲ | 54.127▲ |
| STOCH | 86.765▲ | 41.943 | 68.705 | 71.204 | 52.209 |
| WILL %R | -29.412 | -37.037 | -31.746 | -27.431 | -23.304▲ |
| CCI | 102.722▲ | 10.416 | 62.561 | 40.743 | 166.245▲ |
|
Monday, June 16, 2025 04:00 AM
FDA assigns PDUFA target action date of January 31, 2026; WARREN, N.J., June (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Co ...
|
|
Sunday, June 08, 2025 08:00 PM
Aquestive Therapeutics' Anaphylm offers a unique, non-injectable epinephrine solution for anaphylaxis. Read why AQST stock is a Buy.
|
|
Monday, May 26, 2025 12:36 AM
Aquestive Therapeutics, Inc. (NASDAQ:AQST) shareholders have seen the share price descend 18% over the month. In contrast, the return over three years has been impressive. The share price marched ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/06/25 | 3.22 | 3.53 | 3.22 | 3.42 | 1,219,131 |
| 12/06/25 | 3.36 | 3.395 | 3.2003 | 3.31 | 1,250,953 |
| 11/06/25 | 3.595 | 3.62 | 3.395 | 3.41 | 1,221,974 |
| 10/06/25 | 3.54 | 3.665 | 3.48 | 3.59 | 1,301,917 |
| 09/06/25 | 3.62 | 3.79 | 3.4909 | 3.54 | 2,175,768 |
| 06/06/25 | 3.60 | 3.815 | 3.56 | 3.56 | 2,192,010 |
| 05/06/25 | 3.44 | 3.585 | 3.38 | 3.57 | 2,090,441 |
| 04/06/25 | 3.20 | 3.615 | 3.132 | 3.41 | 3,393,523 |
| 03/06/25 | 2.81 | 3.205 | 2.725 | 3.18 | 2,097,004 |
| 02/06/25 | 2.74 | 2.87 | 2.675 | 2.81 | 1,277,256 |
|
|
||||
|
|
||||
|
|